rs532057230
Variant summary
Our verdict is Benign. The variant received -15 ACMG points: 1P and 16B. PM4_SupportingBP6_Very_StrongBS1BS2
The NM_000293.3(PHKB):c.2459_2461delAAG(p.Glu820del) variant causes a disruptive inframe deletion change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00315 in 1,614,042 control chromosomes in the GnomAD database, including 45 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0045 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0030 ( 40 hom. )
Consequence
PHKB
NM_000293.3 disruptive_inframe_deletion
NM_000293.3 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 9.26
Publications
1 publications found
Genes affected
PHKB (HGNC:8927): (phosphorylase kinase regulatory subunit beta) Phosphorylase kinase is a polymer of 16 subunits, four each of alpha, beta, gamma and delta. The alpha subunit includes the skeletal muscle and hepatic isoforms, encoded by two different genes. The beta subunit is the same in both the muscle and hepatic isoforms, encoded by this gene, which is a member of the phosphorylase b kinase regulatory subunit family. The gamma subunit also includes the skeletal muscle and hepatic isoforms, encoded by two different genes. The delta subunit is a calmodulin and can be encoded by three different genes. The gamma subunits contain the active site of the enzyme, whereas the alpha and beta subunits have regulatory functions controlled by phosphorylation. The delta subunit mediates the dependence of the enzyme on calcium concentration. Mutations in this gene cause glycogen storage disease type 9B, also known as phosphorylase kinase deficiency of liver and muscle. Alternatively spliced transcript variants encoding different isoforms have been identified in this gene. Two pseudogenes have been found on chromosomes 14 and 20, respectively.[provided by RefSeq, Feb 2010]
PHKB Gene-Disease associations (from GenCC):
- glycogen storage disease IXbInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, ClinGen, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -15 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in NM_000293.3. Strenght limited to Supporting due to length of the change: 1aa.
BP6
Variant 16-47669238-TGAA-T is Benign according to our data. Variant chr16-47669238-TGAA-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 257176.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0045 (686/152278) while in subpopulation NFE AF = 0.00272 (185/68014). AF 95% confidence interval is 0.0024. There are 5 homozygotes in GnomAd4. There are 445 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PHKB | NM_000293.3 | c.2459_2461delAAG | p.Glu820del | disruptive_inframe_deletion | Exon 26 of 31 | ENST00000323584.10 | NP_000284.1 | |
| PHKB | NM_001363837.1 | c.2459_2461delAAG | p.Glu820del | disruptive_inframe_deletion | Exon 26 of 31 | NP_001350766.1 | ||
| PHKB | NM_001031835.3 | c.2438_2440delAAG | p.Glu813del | disruptive_inframe_deletion | Exon 27 of 32 | NP_001027005.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00451 AC: 686AN: 152160Hom.: 5 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
686
AN:
152160
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00496 AC: 1247AN: 251212 AF XY: 0.00483 show subpopulations
GnomAD2 exomes
AF:
AC:
1247
AN:
251212
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00301 AC: 4394AN: 1461764Hom.: 40 AF XY: 0.00294 AC XY: 2138AN XY: 727194 show subpopulations
GnomAD4 exome
AF:
AC:
4394
AN:
1461764
Hom.:
AF XY:
AC XY:
2138
AN XY:
727194
show subpopulations
African (AFR)
AF:
AC:
11
AN:
33476
American (AMR)
AF:
AC:
65
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
26134
East Asian (EAS)
AF:
AC:
0
AN:
39698
South Asian (SAS)
AF:
AC:
0
AN:
86254
European-Finnish (FIN)
AF:
AC:
1899
AN:
53418
Middle Eastern (MID)
AF:
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
2276
AN:
1111906
Other (OTH)
AF:
AC:
141
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
217
434
651
868
1085
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
82
164
246
328
410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00450 AC: 686AN: 152278Hom.: 5 Cov.: 32 AF XY: 0.00598 AC XY: 445AN XY: 74464 show subpopulations
GnomAD4 genome
AF:
AC:
686
AN:
152278
Hom.:
Cov.:
32
AF XY:
AC XY:
445
AN XY:
74464
show subpopulations
African (AFR)
AF:
AC:
15
AN:
41556
American (AMR)
AF:
AC:
30
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5188
South Asian (SAS)
AF:
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
AC:
447
AN:
10612
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
185
AN:
68014
Other (OTH)
AF:
AC:
8
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
32
65
97
130
162
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Aug 31, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jul 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
PHKB: BS1, BS2 -
Glycogen phosphorylase kinase deficiency Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Glycogen storage disease IXb Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.